|
|
 |
[2026/05/29] |
 |
|
 |
 |

Manuscript Accepted !! |
 |
|
|
³í¹®Á¦¸ñ: The Ubiquitin-Proteasome System: A Master Regulator of Cell Cycle Progression.
Àú³Î: Pharmacological Research (2025 Impact factor: 10.5) |
|
|
|
|
 |
[2026/05/26] |
 |
|
 |
 |

±¹³»Æ¯Çã µî·Ï ! |
 |
|
|
¹ß¸íÀÇ ¸íĪ: ´ëÀå¾Ï Áø´Ü¿¡ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϱâ À§ÇÑ ºÐ¼®¹æ¹ý
Ãâ¿øÀÏ: 2024.09.10
µî·ÏÀÏ: 2026.05.19
Ãâ¿ø¹øÈ£: 10-2024-0122855
µî·Ï¹øÈ£: 10-2968330 |
|
|
|
|
 |
[2026/05/23] |
 |
|
 |
 |

Manuscript Accepted !! |
 |
|
|
³í¹®Á¦¸ñ: Key regulatory pathways in recurrent pregnancy loss: Integrating trophoblast dysfunction, angiogenesis, and inflammatory signaling
Àú³Î: Biomedicine & Pharmacotherapy (2025 Impact factor: 7.5) |
|
|
|
|
 |
[2026/05/14] |
 |
|
 |
 |

Manuscript Accepted !! |
 |
|
|
³í¹®Á¦¸ñ: The USP19-DnaJC7 axis regulates p53 stability in cisplatin-treated
epithelial ovarian cancer.
Àú³Î: Cells (2025 Impact factor: 5.2) |
|
|
|
|
 |
[2026/05/06] |
 |
|
 |
 |

Manuscript Accepted !! |
 |
|
|
³í¹®Á¦¸ñ: Dysregulation of the ubiquitin–proteasome system in aging skeletal muscle.
Àú³Î: Biomedicine & Pharmacotherapy (2025 Impact factor: 7.5) |
|
|
|
|
|